Clinical Evaluation of Approved Contact Lenses

Exclusion Criteria

• •1. Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
• •2. Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• •3. Any systemic disease, autoimmune disease, or use of medication that may interfere with contact lens wear.
• •4. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia.
• •5. Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.)
• •6. Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
• •7. Any known hypersensitivity or allergic reaction to OPTI-FREE® PureMoist® Contact Lens Solution.
• •8. Any ocular infection.
• •9. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• •10. Monovision or multi-focal contact lens correction.
• •11. Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
• •12. History of binocular vision abnormality or strabismus.
• •13. Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV, by self-report).
• •14. Suspicion of or recent history of alcohol or substance abuse.
• •15. History of serious mental illness.
• •16. History of seizures.
• •17. Employee of investigational clinic (e.g., Investigator, Coordinator, Technician)